These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33145286)

  • 1. Analysis of preoperative circulating tumor cells for recurrence in patients with hepatocellular carcinoma after liver transplantation.
    Chen Z; Lin X; Chen C; Chen Y; Zhao Q; Wu L; Wang D; Ma Y; Ju W; Chen M; He X
    Ann Transl Med; 2020 Sep; 8(17):1067. PubMed ID: 33145286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative circulating tumor cells to predict microvascular invasion and dynamical detection indicate the prognosis of hepatocellular carcinoma.
    Zhou J; Zhang Z; Zhou H; Leng C; Hou B; Zhou C; Hu X; Wang J; Chen X
    BMC Cancer; 2020 Oct; 20(1):1047. PubMed ID: 33129301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mesenchymal circulating tumor cells as biomarker for prognosis prediction and supervision in hepatocellular carcinoma.
    Zhao L; Zheng Z; Liu Y; Liu F; Li X; Wu Z
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6035-6048. PubMed ID: 36633681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
    Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
    Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Preoperative NANOG-Positive Circulating Tumor Cell Levels With Recurrence of Hepatocellular Carcinoma.
    Lei Y; Wang X; Sun H; Fu Y; Tian Y; Yang L; Wang J; Xia F
    Front Oncol; 2021; 11():601668. PubMed ID: 34123777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating tumor cell associated white blood cell cluster as a biomarker for metastasis and recurrence in hepatocellular carcinoma.
    Chen J; Luo Y; Xi X; Li H; Li S; Zheng L; Yang D; Cai Z
    Front Oncol; 2022; 12():931140. PubMed ID: 36465354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of circulating tumour cells enables early recurrence prediction in hepatocellular carcinoma patients undergoing liver transplantation.
    Wang PX; Xu Y; Sun YF; Cheng JW; Zhou KQ; Wu SY; Hu B; Zhang ZF; Guo W; Cao Y; Huang XW; Zhou J; Fan J; Yang XR
    Liver Int; 2021 Mar; 41(3):562-573. PubMed ID: 33205544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection.
    Sun YF; Xu Y; Yang XR; Guo W; Zhang X; Qiu SJ; Shi RY; Hu B; Zhou J; Fan J
    Hepatology; 2013 Apr; 57(4):1458-68. PubMed ID: 23175471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of circulating tumor cells in the portal vein regarding metastases and vascular invasion in hepatocellular carcinoma patients.
    Zhao X; Zhao J; Tao L; Pan Y; Yang L; Zhang X; Yuan J; Zhu H
    J Gastrointest Oncol; 2021 Dec; 12(6):3050-3060. PubMed ID: 35070429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 3D Culture of Circulating Tumor Cells for Evaluating Early Recurrence and Metastasis in Patients with Hepatocellular Carcinoma.
    Hu CL; Zhang YJ; Zhang XF; Fei X; Zhang H; Li CG; Sun B
    Onco Targets Ther; 2021; 14():2673-2688. PubMed ID: 33888992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clearance of Circulating Tumor Cells in Patients with Hepatocellular Carcinoma Undergoing Surgical Resection or Liver Transplantation.
    Amado V; González-Rubio S; Zamora J; Alejandre R; Espejo-Cruz ML; Linares C; Sánchez-Frías M; García-Jurado G; Montero JL; Ciria R; Rodríguez-Perálvarez M; Ferrín G; De la Mata M
    Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34069569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor Cells as an Indicator of Treatment Options for Hepatocellular Carcinoma Less Than or Equal to 3 cm in Size: A Multi-Center, Retrospective Study.
    Zhang Q; Xia F; Gao H; Wu Z; Cao W; Xiang Q; Guan Z; Su Y; Zhang W; Chen W; Mo A; Li S
    Front Surg; 2022; 9():895426. PubMed ID: 35795230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating Tumor Cell Phenotype Indicates Poor Survival and Recurrence After Surgery for Hepatocellular Carcinoma.
    Ou H; Huang Y; Xiang L; Chen Z; Fang Y; Lin Y; Cui Z; Yu S; Li X; Yang D
    Dig Dis Sci; 2018 Sep; 63(9):2373-2380. PubMed ID: 29926241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of a novel liquid biopsy in patients with hepatocellular carcinoma undergoing liver transplantation.
    Xue F; Shi S; Zhang Z; Xu C; Zheng J; Qin T; Qian Z; Zhao X; Tong Y; Xia L; Xia Q
    Oncol Lett; 2018 Apr; 15(4):5481-5488. PubMed ID: 29552189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection.
    Zhou Y; Wang B; Wu J; Zhang C; Zhou Y; Yang X; Zhou J; Guo W; Fan J
    BMC Cancer; 2016 Jul; 16():506. PubMed ID: 27439521
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-derived proliferative CTCs and CTC clusters predict aggressiveness and early recurrence in hepatocellular carcinoma patients.
    Zhao L; Song J; Sun Y; Ju Q; Mu H; Dong X; Ding J; Liu Y; Wang X; Sun L; Wu J; Jiao Y; Lu S; Zhao X
    Cancer Med; 2023 Jul; 12(13):13912-13927. PubMed ID: 37337648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine: A novel prognostic biomarker in liver transplantation for alpha-fetoprotein- negative hepatocellular carcinoma.
    Yang M; Tan W; Yang X; Zhuo J; Lin Z; Cen B; Lian Z; Li H; Lu D; Wei X; Zheng S; Xu X
    Cancer Biomark; 2020; 29(2):197-206. PubMed ID: 32623388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating Tumor Cells Undergoing the Epithelial-Mesenchymal Transition: Influence on Prognosis in Cytokeratin 19-Positive Hepatocellular Carcinoma.
    Zhang Q; Xing W; Zhang J; Hu J; Qi L; Xiang B
    Onco Targets Ther; 2021; 14():1543-1552. PubMed ID: 33688202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of circulating tumor cells in patients with hepatocellular carcinoma recurrence following liver transplantation.
    Wang S; Zheng Y; Liu J; Huo F; Zhou J
    J Investig Med; 2018 Jun; 66(5):1-6. PubMed ID: 29632031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Presence of Circulating Tumor Cell Cluster Characterizes an Aggressive Hepatocellular Carcinoma Subtype.
    Yu JJ; Shu C; Yang HY; Huang Z; Li YN; Tao R; Chen YY; Chen Q; Chen XP; Xiao W
    Front Oncol; 2021; 11():734564. PubMed ID: 34722281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.